Search company, investor...

Nantong Hemeijia

Stage

Corporate Majority | Acquired

Valuation

$0000 

About Nantong Hemeijia

Nantong Hemeijia is a for-profit Grade II hospital located in Nantong, Jiangsu Province, providing private obstetrics and gynecology specialty hospital services.

Headquarters Location

Nantong, Jiangsu,

China

Missing: Nantong Hemeijia's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Nantong Hemeijia's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Nantong Hemeijia

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nantong Hemeijia is included in 1 Expert Collection, including Women's Health & Wellness.

W

Women's Health & Wellness

1,484 items

Startups focused on providing products and services catering to women's health and wellbeing.

Latest Nantong Hemeijia News

China: Harmonicare to acquire 51% stake in Nantong Hemeijia

Jul 12, 2017

Analysis: Expats and mental health Mental health is a growing issue for expats; workers and their employers, as well as those relocating independently, according to a recent research study by Aetna International. Expatriate mental health: breaking the silence and ending the stigma, calls for businesses and individuals to take more pre-emptive action to combat the problem, to ensure expats have the vital support they need when relocating or working away from their home country. Anaysis: How to improve outcomes for stroke patients in China A new programme, launched by the Chinese Stroke Association (CSA) and the American Stroke Association (ASA) is aiming to improve the treatment for, and prevention of, cardiovascular and stroke events by helping hospitals and providers consistently adhere to the latest scientific treatment guidelines. Analysis: Oventus pushes forward Brisbane-based Oventus has had a good week. First and foremost the sleep disorder device manufacturer has just completed the first tranche of capital raising. It has raised A$6.5 million (US$4.9 million) in a placement of shares at A$0.36 per share. A second tranche to raise A$0.5 million will follow subject to shareholder approval. Bell Potter is managing the deal. Analysis: The risk of regret A new report from QBE Insurance, Australia's largest global insurer, reveals that 22% of healthcare companies in Hong Kong have suffered from legal and regulatory compliance issues over the past 12 months. The Risks of Regret report looks at both current and future business challenges and opportunities, and how well-prepared companies are to deal with risks. Analysis: The opportunities of diabetes in Asia “The Asia-Pacific region presents lucrative opportunities for multinational pharmaceutical firms that treat diabetes,” says BMI Research in Singapore in a new report on healthcare in Asia. Fuelled by rapid urbanisation, nutrition transition and increasingly sedentary lifestyles, the epidemic has grown in parallel with the worldwide rise in obesity. Asia’s large population and rapid economic development have made it an epicentre of the epidemic, with India and China the key hotspots in the region, it explains.

Nantong Hemeijia Frequently Asked Questions (FAQ)

  • Where is Nantong Hemeijia's headquarters?

    Nantong Hemeijia's headquarters is located at Nantong.

  • What is Nantong Hemeijia's latest funding round?

    Nantong Hemeijia's latest funding round is Corporate Majority.

  • Who are the investors of Nantong Hemeijia?

    Investors of Nantong Hemeijia include HarMoniCare Medical.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.